⌘K

Home/Filings/4/0001127602-25-006135

4//SEC Filing

Birkett Bernard 4

Accession 0001127602-25-006135

CIK 0000105770other

View on SEC.gov Company Profile

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 9:44 PM ET

Size

16.0 KB

Accession

0001127602-25-006135

Insider Transaction Report

Form 4

Period: 2025-02-18

WEST PHARMACEUTICAL SERVICES INCWST

Birkett Bernard

Sr VP, Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2025-02-18$211.00/sh+779.353$164,443→ 7,668.773 total
Award
Rst. Stock Unit
2025-02-18+1,740→ 1,740 total
Exercise: $0.00→ Common Stock (1,740 underlying)
Tax Payment
Common Stock
2025-02-18$211.00/sh−237.764$50,168→ 7,431.009 total
Exercise/Conversion
Common Stock
2025-02-18$211.00/sh+124.977$26,370→ 7,555.986 total
Tax Payment
Common Stock
2025-02-18$211.00/sh−35.606$7,513→ 7,520.38 total
Award
Stock Option (Right to Buy)
2025-02-18+4,020→ 4,020 total
Exercise: $211.00From: 2026-02-18Exp: 2035-02-18→ Common Stock (4,020 underlying)

Footnotes (1)

[F1]This award vests in four equal installments beginning on February 18, 2026.

Documents

2 files

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1

filerCIK 0001658001

Filing Metadata

Form type: 4
Filed: Feb 19, 7:00 PM ET
Accepted: Feb 20, 9:44 PM ET
Size: 16.0 KB

View on SEC.gov